Centerspace executive awarded 4,895 restricted stock units

Centerspace executive reports new equity award.

Accepted by SEC EDGAR 01/05/2026 - 12:25 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Centerspace executive reports new equity award. A Form 4 filing for Centerspace (CSR) discloses that an officer serving as EVP and CFO received a grant of 4,895 restricted stock units. The award has a conversion price of $0 per unit and relates to common shares of beneficial interest. According to the filing, this represents a time-based contingent right to receive 4,895 common shares, vesting over three years in one-third increments on each anniversary of the grant date on January 1, 2027, 2028 and 2029. Following this transaction, the reporting person beneficially owns 4,895 derivative securities directly.

Insider Trade Summary

Grant/Award: 4,895 shares

Grant/Award 1 txn

Insider Patel Bhairav

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	4,895	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 4,895 contracts (Direct)

Footnotes (1)

1. F1. Represents a time-based contingent right to receive 4,895 common shares of beneficial interest of Centerspace vesting over three years in one-third increments on each anniversary of the grant date: January 1, 2027, 2028 and 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Centerspace (CSR) report in this Form 4?

The Form 4 reports that an executive officer of Centerspace (CSR), serving as EVP and CFO, received 4,895 restricted stock units tied to common shares of beneficial interest.

How many restricted stock units were granted to the Centerspace EVP and CFO?

The EVP and CFO of Centerspace received a grant of 4,895 restricted stock units, each representing a contingent right to receive one common share of beneficial interest.

What is the vesting schedule for the 4,895 Centerspace restricted stock units?

The 4,895 restricted stock units vest over three years in one-third increments on each anniversary of the grant date: January 1, 2027, January 1, 2028, and January 1, 2029.

What is the exercise or conversion price of the Centerspace restricted stock units?

The filing states that the restricted stock units have a conversion or exercise price of $0, which is typical for time-based stock unit awards.

How many derivative securities does the reporting person own after this Centerspace transaction?

After the reported transaction, the reporting person beneficially owns 4,895 derivative securities, held directly, according to the Form 4.

What class of Centerspace securities underlies the restricted stock units?

The restricted stock units are linked to common shares of beneficial interest of Centerspace, as specified in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patel Bhairav

(Last) (First) (Middle)

C/O CENTERSPACE

1324 20TH AVENUE SW

(Street)

MINOT ND 58701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CENTERSPACE [ CSR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	01/01/2026		A		4,895(1)		01/01/2027	01/01/2029	Common Shares of Beneficial Interest	4,895	$0	4,895	D

Explanation of Responses:

1. Represents a time-based contingent right to receive 4,895 common shares of beneficial interest of Centerspace vesting over three years in one-third increments on each anniversary of the grant date: January 1, 2027, 2028 and 2029.

Remarks:

	Anne Olson, Attorney in Fact for Bhairav Patel	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.